Evidence map›Paper›PMID 32843089›Full record

ArticleInfectious diseases of poverty2020

Epidemiology of tuberculosis in Sabah, Malaysia, 2012-2018.

Michelle May D Goroh, Giri Shan Rajahram, Richard Avoi, Christel H A Van Den Boogaard, Timothy William, Anna P Ralph, Christopher Lowbridge

Abstract readComparative Study
In one paragraph

Article in Infectious diseases of poverty, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Demography and clinical pattern of newly diagnosed uveitis patients in Malaysia.Journal of ophthalmic inflammation and infection · 2022
    Article
  13. Article
  14. Tuberculosis Death Epidemiology and Its Associated Risk Factors in Sabah, Malaysia.International journal of environmental research and public health · 2021
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michelle May D GorohTB/Leprosy Control Unit, Sabah State Health Department, Kota Kinabalu, Malaysia.
Giri Shan RajahramQueen Elizabeth Hospital, Kota Kinabalu, Malaysia.
Richard AvoiFaculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.
Christel H A Van Den BoogaardMenzies School of Health Research, Charles Darwin University, Darwin, Australia.
Timothy WilliamInfectious Diseases Society of Kota Kinabalu, Kota Kinabalu, Malaysia.
Anna P RalphMenzies School of Health Research, Charles Darwin University, Darwin, Australia.
Christopher LowbridgeMenzies School of Health Research, Charles Darwin University, Darwin, Australia. christopher.lowbridge@menzies.edu.au.ORCID http://orcid.org/0000-0001-8307-9583

Funding

Department of Foreign Affairs and Trade, Australian Government 1132089National Health and Medical Research Council 1131932National Health and Medical Research Council 1142011
6 · The paper itself

Abstract

backgroundTuberculosis (TB) is of high public health importance in Malaysia. Sabah State, located on the island of Borneo, has previously reported a particularly high burden of disease and faces unique contextual challenges compared with peninsular Malaysia. The aim of this study is to describe the epidemiology of TB in Sabah to identify risk groups and hotspots of TB transmission.

methodsWe conducted a retrospective review of TB cases notified in Sabah, Malaysia, between 2012 and 2018. Using data from the state's 'myTB' notification database, we calculated the case notification rate and described trends in the epidemiology, diagnostic practices and treatment outcomes of TB in Sabah within this period. The Chi-squared test was used for determining the difference between two proportions.

resultsBetween 2012 and 2018 there were 33 193 cases of TB reported in Sabah (128 cases per 100 000 population). We identified several geographic hotspots, including districts with > 200 cases per 100 000 population per year. TB rates increased with age and were highest in older males. Children < 15 years accounted for only 4.6% of cases. Moderate or advanced disease on chest X-ray and sputum smear positivity was high (58 and 81% of cases respectively), suggesting frequent late diagnosis. Multi-drug resistant (MDR) TB prevalence was low (0.3% of TB cases), however, rapid diagnostic test coverage was low (1.2%) and only 18% of all cases had a positive culture result. Treatment success was 83% (range: 81-85%) in those with drug-sensitive TB and 36% (range: 25-45%) in cases of MDR-TB.

conclusionBetween 2012 and 2018, TB notifications in Sabah State equated to 20% of Malaysia's total TB notifications, despite Sabah representing only 10% of Malaysia's population. We found hotspots of TB in urbanised population hubs and points of migration, as well as evidence of late presentation and diagnosis. Ensuring universal health coverage and expansion of GeneXpert® coverage is recommended to reduce barriers to care and early diagnosis and treatment for TB.

Indexed as

AdolescentAdultAgedAge DistributionAntitubercular AgentsChildChild, PreschoolFemaleHumansMalaysiaMaleMiddle AgedRetrospective StudiesRisk FactorsSex DistributionTreatment OutcomeAntitubercular AgentsEpidemiologyMalaysiaSabahSurveillanceTuberculosis

Identifiers

PMID32843089
PMCPMC7447595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.